GSTM1 and Gastrointestinal angiodysplasia: A recent meta-analysis of 11 studies including 212 non-HHT patients with GI angiodysplasias, support the effectiveness of SA with an improvement of Hb levels by 30 g/L and a reduction of more than 50% of RBC transfusion requirements in 83% of patients (25).